Vidac Pharma Holding Plc (HAM:T9G)

Germany flag Germany · Delayed Price · Currency is EUR
0.800
+0.230 (40.35%)
At close: Mar 9, 2026
21.21%
Market Cap 30.25M
Revenue n/a
Net Income n/a
Shares Out n/a
EPS n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,950
Average Volume 4,092
Open 0.800
Previous Close 0.570
Day's Range 0.800 - 0.800
52-Week Range 0.450 - 0.800
Beta n/a
RSI 77.62
Earnings Date Jun 30, 2026

About Vidac Pharma Holding

Vidac Pharma Holding Plc, an investment holding company, engages in the discovery and development of medicines for oncologic and dermatologic diseases. The company is developing VDA-1102 ointment, an anti-neoplastic agent that is in Phase 2 clinical trials for triggering apoptosis in cancer cells with minimal effects on surrounding normal cells. It is also developing VDA-1102 IV, an anti-neoplastic agent; and VDA-1275, a potent small molecule new chemical entity that are in preclinical stage for use in the treatment of solid tumors. The company... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2021
Country United Kingdom
Stock Exchange Hamburg Stock Exchange
Ticker Symbol T9G
Full Company Profile

News

There is no news available yet.